Hypercholesterolemia and associated cardiovascular complications continue to occur in a great number of people. However, certain coastal populations have lower incidence of cardiovascular and other diseases, which may be attributed to regular intake of seaweeds in their diet. Seaweeds contain sulphated polysaccharides (SPS) which demonstrate a wide spectrum of biomedical properties and are phytochemical analogues of mammalian heparin sulphate. This knowledge served as the major impetus for exploring the therapeutic potential of SPS from the brown algae Sargassum wightii and SPS from Fucus vesiculosus in experimental rats against diet-induced hyperlipidemia and associated inflammatory complications. Adult male Wistar rats were divided into six groups with six rats in each. The control group (group I) was left untreated while group II rats were fed with a high cholesterol diet (CCT diet -normal rat chow with 4% cholesterol, 1% cholic acid and 0.5% thiouracil) for 14 days. Rats in groups III and IV received SPS from S. wightii (SW group) and SPS from R vesiculosus (FV group) (5mg/kg b.wtlday, subcutaneously) during the last 7 days, respectively. Rats in groups V and VI were fed with a high cholesterol diet for 14 days and in addition were given SPS from S. wightii (CCT + SW group) and SPS from R vesiculosus (CCT + FV group) at the weight of5mg/kg b.wt/day, subcutaneously during the last 7 days, respectively. The adverse effects of hypercholesterolemia were evident from increased levels of serum lipid status and inflammatory complications manifested by augmented levels of plasma tumour necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP), fibrinogen, inducible nitric oxide synthase (iNOS), nitric oxide (NO), cyclooxygenase (COX-2) and lysosomal enzymes. Treatment with algal SPS considerably restored the above abnormalities. SPS from S. wightii and SPS from F. vesiculosus were almost equally effective in mitigating hypercholesterolemia and related inflammatory complications. Cardiovascular diseases (CVD) will be responsible for 36% of all deaths and the leading cause of death in the world by the year 2020 (1). CVD, including coronary heart disease, stroke and peripheral vascular disease are the clinical manifestations of advanced atherosclerosis (2).
cap, leading to rupture and thrombus formation (3) .
The complications of hypercholesterolemic atherogenesis may derive from activation of the inflammatory mechanisms fuelled by high lipid levels in the body. There is always a search for new therapeutic strategies beyond lipid lowering to mitigate vascular inflammation and cytotoxic aberrations associated with atherosclerosis. Certain coastal populations have fewer incidences of CVD and low levels of blood cholesterol, which may be attributed to the regular consumption of seaweeds in their diet (4) . Seaweeds contain sulphated polysaccharides (SPS) that are credited with multiple biological properties. They are also phytochemical analogues of mammalian heparin sulphate (5) . The above reports prompted us to evaluate SPS from the native brown algae Sargassum wightii and compare its efficacy with the commercially available fucoidan (SPS, Fucus vesiculosus) on lowering the serum lipids and inflammatory complications.
MATERIALS AND METHODS

Chemicals
Fucoidan (SPS, F vesiculosus) and Bovine serum albumin were obtained from Sigma Chemicals, St.Louis, MO, USA. All other chemicals and solvents used were of analytical grade.
Seaweed collection and SPS extraction
. The brown algae S. wightii was collected from Mandapam, Gulf of Mannar region, Rameswaram, India. The seaweeds were thoroughly washed, shade-dried, coarsely powdered and subjected to further analysis. SPS from S. wightii was extracted according to the method of Vieira et al., (6) with slight modifications.
Experimental animals
Thirty-six adult male albino rats of Wistar strain, weighing 140 ± 109 were procured from Tamilnadu Veterinary and Animal Sciences University, Chennai. The animals were housed in large spacious cages under standard conditions of relative humidity (55 ± 10 %), temperature (25 ± 2°C) and well ventilated with 12 h light /12 h dark cycle throughout the experimental period. The experiments were conducted in accordance with the guidelines of the Institutional Animal Ethics Committee (IAEC No. 03/003/04).
Study design
The animals were divided into six groups with six rats in each as follows. (7) .
Fourier transform-infrared (FT-IR) spectroscopy
FT-IR spectra of algal SPS were recorded with an IR spectrophotometer between 4000 and 400 cnr'. The samples (10 mg) were analyzed as a KBr pellet. The FT-IR spectrum of SPS from S.wightii was compared with that of SPS from F vesiculosus.
Analysis oflipid profile and lipid metabolism
Total cholesterol (TC) and Triglycerides (TG) were determined by the methods of Parekh and lung (8) and Rice (9) , respectively. The lipoproteins were fractionated by a dual precipitation technique (10) . After fractional precipitation, lipoprotein cholesterol was estimated (8) . The activities of lipid metabolizing enzymes viz., Lecithin:Cholesterol acyl transferase (LCAT), Lipoprotein lipase (LPL) and Cholesterol ester synthetase (CES) were quantified according to the procedures described by Legrand et al. (11), with the modifications of Hitz et al. (12) , Baginsky (13) and Kothari et al. (14) , respectively. Cholesterol ester hydrolase (CEH) levels were determined by the method of Kothari et al. (15) , with slight modification by Kritchevsky and Kothari (16) .
Measurement of Tumour necrosis factor-alpha (TNFalpha) levels
Protein content of the serum and the cardiac tissue were estimated by the method of Lowry et al. (17) . The serum levels of TNF-alpha were measured using rat ELISA immunoassay kit by Bender MedSystem, Austria. The intensity of the color was recorded in an ELISA reader at 450 nm. The level ofTNF-alpha was expressed as pg/mg protein.
Assay of plasma C-reactive protein (CRP) and fibrinogen CRP was quantitatively determined by a turbidometric assay with the reagent CRP-Turbilatex agglutination assay kit (SPINREACT, Spain) whose absorbance was read at 540 nm, and levels were expressed in mg/l. Fibrinogen was estimated by the method of Lempert (18) and the levels were expressed as mg/dl.
Measurement of cardiac inducible nitric oxide synthase (iNOS) mRNA levels Extraction oftotal RNA
Total RNA from cardiac tissue was isolated according to the manufacturer's instructions (Trizol, One-step RNA isolation kit, Medox Biotech Pvt Ltd.). The purity and yield of RNA was quantified by measuring the absorbance of RNA solution at 260 nm and 280 nm.
Reverse transcriptase-polymerase chain reaction (RT-PCR) for iNOS mRNA levels
RT-PCR for iNOS mRNA expression was carried out according to the manufacturer's guidelines (Qiagen One
Step RT-PCR mix). After initial reverse transcription at 50°C for 60 min, the initial PCR activation step was carried out at 94°C for 15 min to inactivate reverse transcriptase and denature cDNA template. This was followed by denaturation at 94°C for 15 sec, annealing at 60°C for 40 sec and extension at noc for 30 sec for 39 cycles. Final extension was carried out at noc for 5 min and the reaction was terminated by holding the temperature at 4°C. RT-PCR products were resolved onto 2% agarose gels and quantified by densitometry using housekeeping product as internal control. The primer sequences and gene accession number for target (iNOS) and housekeeping gene are presented in Table I .
Estimation of plasma and cardiac nitrite and nitrate levels
The concentration of total Nitric Oxide (NO) was measured by the enzymatic conversion of nitrate to nitrite by nitrate reductase in the system (R&D Systems, Minneapolis, USA). The reaction is followed by a colorimetric detection of nitrite as an azo dye product of the Griess Reaction.
Measurement of cardiac cycloxygenase (COX-2) mRNA levels
Total RNA was extracted from the heart and reverse transcription reaction was performed at 50°C for 50 min, initial PCR activation was carried out at 95°C for 5 min, followed by 28 cycles at 94°C (denaturation) for 15 sec, 58°C (annealing) for 15 sec and noc (extension) for I min, and finally incubated at noc for 10 min to extend any incomplete single strands. The expression of each target gene was standardized with internal control gene whose primer sequences are shown in Table I .
Analysis oflysosomal enzymes
Acid phosphatase (ACP), N-Acetyl glucosaminidase (NAG) and Cathepsin-D were quantified following the methods of King (19) , Maruhn (20) and Etherington (21), respectively. Beta-Glucuronidase (Beta-Glu) and Beta-Galactosidase (Beta-Gal) were estimated by the method of Kawai and Anno (22) .
Statistical analysis
The results are expressed as mean values ± standard deviation (S.D.) for six animals in each group. Differences between groups were assessed by ANOVA using the SPSS (Statistical Package for Social Sciences) software package for Windows. Post hoc testing was performed for inter- Table I . Primer sequences ofthe target and housekeeping gene for iNOS and COX 2 mRNA. 
RPL-19
Sense: 5'-CTG AAG GTC AAA GGG AAT GTG -3'
[BC058135] 195 Anti-sense: 5' -GGA CAG AGT CTT GAT GAT CTC -3' group comparisons usingthe Least Significance Difference (LSD) test; significance at p -values <0.001, <0.01, <0.05 havebeengiven respective symbols in the tables.
RESULTS
FT-IR spectra for SPS from s. wightii and SPS from F. vesiculosus FT-IR spectra for SPS extracted from S. wightii had absorption bands at 1229 cm' and 592 em:' corresponding to the sulphate groups. SPS from F. vesiculosus had absorption bands at 1264 -1231 em I and 585 cm' corresponding to the sulphate groups. The presence of hydroxyl group and aliphatic 'CH' bond were identified by intense broad absorption band at 3436 em:' and relatively narrow band at 2924 em:', respectively. Absorption at 1632 crrr' (SPS, S. wightii) and 1629 cm' (SPS, F. vesiculosus) are attributed to C = C groups. Secondary alcohol, C-OH group is represented at 1021 cm' for SPS from S. wightii and 1018 em:' for SPS from F. vesiculosus. SPS from S. wightii had a FT-IR spectrum similar to that of fucoidan (SPS, F. vesiculosus) and the absorption bands correspond to polysaccharides with sulphate groups (figures not shown).
Alterations in lipid status
Table II depicts the significant increase (p<O.OOl) in the serum levels of TC, TG and atherogenic lipoprotein fractions (LDLand VLDL), accompanied by a decline (p<O.OOl) in the level of HDL cholesterol. The rats on CCT diet, treated with algal SPS had pronounced decline in hyperlipidemia.
CCT group rats also showed a pronounced decrease in the plasma levels of lipid metabolizing enzymes like LCAT, LPL and CEH by 31%, 37% and 20% respectively, in comparison with the control. Correspondingly, there was a 32% increase in the plasma CES activity. Treatment with algal SPS considerably increased their activities (LCAT -17%, LPL -33% and CEH-19%) in CCT+SW and (LCAT -28%, LPL -35%, CEH -19%) in CCT+FV groups. Plasma CES activity was decreased by 29% and 30% in CCT+SW and CCT+FV groups, respectively. 
Biochemical markers of Inflammation: Appraisal of seru m TNF-alpha, CRP andfibrinogen
In the present study, hypercholesterolemiainduced inflammatory stress was evident from the increased (2.37-, 2.3-and 4.04 -fold) levels of serum pro-inflammatory cytokine TNF-alpha, CRP and fibrinogen, respectively in CCT diet fed rats . Alga l SPS administration significantly depressed the above abnormal levels by 1.06-, 1.2-and 2.84-fold in both the CCT+SW and CCT+FV groups.
iNOS-COX-2 inflammatory cascade
The inflamm atory changes due to hypercholesterolemia were further envisioned In the current study by the predominant rise in iNOS , NO and COX-2 levels. The mRNA leve ls of cardiac iNOS and COX-2 were confirmed by RT-PCR, whic h showed a single transcript at 305bp and 759bp respectively, in all the groups (Figs . I and  2) . Densitometric analysis showed a significan t (p<O.OOl) increase in the iNOS and COX -2 mRNA levels, under hypercho lestero lemic condition (Figs . I and 2). CCT group rats also showed increased levels of NO in the plasma (p<0.05) and heart tissue (p<O.OO l). Treatment with algal SPS significantly decreased the cardiac iNOS and COX-2 mRNA levels ( Figs. 1 and 2) . Plasma NO con centration was decreased by 0.83-fold in CCT+SW and by I-fold in the CCT+FV group. Cardiac NO levels were reduced by 0.25-fold in both the CCT+SW and CCT+FV groups.
Inflammation and lysosomal instability
There was a significant increase (p<O.OOI) in the plasma lysosomal enzymes viz., Beta-Glu, Beta-gal, ACP, Cat 0 and NAG in CCT diet fed rats (Table  Ill) . SPS were effective in considerably restoring the lysosomal enzymes (Table Ill) .
DISCUSSION
The FT-IR spectra of S. wightii and F vesiculosus had near similar absorption bands corresponding to polysaccharides with sulphate groups. Supportive to this, Ruperez et a1., (23) previously reported that the polysaccharide fractions from F vesiculosus show absorption bands at 1225-1255 cm', due to the sulphate group. The normal FT-IR spectra of the polysaccharides show bands at 1260, 836, 615 and 580 cm' assigned to sulphate groups (24) . The FT-IR spectra of the fractions of the brown marine algae Padina gymnospora showed an intense absorption band at 1264 cm' (S=O) common to all the sulphate groups. Absorption bands at 3330 cm' correspond to the hydroxyl group (25) . Hence S. wightii extract can be designated as algal SPS.
SPS from S. wightii and SPS from F vesiculosus reduced the TC and TG levels in the serum (Table  II) , probably by delaying the intestinal absorption of cholesterol or hastening cholesterol excretion by modulating cholesterol 7alpha-hydroxylase activity, a key enzyme in the conversion of cholesterol to bile acids. Furthermore, they had a positive effect on the lipoprotein fractions with reduced LDL and VLDL cholesterol levels, accompanied by an elevated HDL cholesterol concentration (Table II) substantiating their role in 'reverse cholesterol transport' mode of cholesterol elimination. The results concur with that of Pengzhan et aI. (26) .
The pronounced decline in plasma LCAT and LPL activities may be attributed to the lesser availability of HDL (Table II) , a substrate for LCAT, and high circulating fatty acid levels due to a cholesterol rich diet, respectively. In addition, decline in LPL activity leads to decreased TG clearance (27) which may contribute to high levels of TG in CCT group animals (Table II) . The substrates provided by the elevated TC levels (Table II) might have contributed to the sharp increase in the plasma CES activities in atherogenic group rats. The results agree with those of Shanmugasundaram and Parthasarathy (28) . The decline in the plasma CEH activity may be an attempt to suppress further increase in the levels of FC.
Inflammation begets cytokines, like TNF -a, which in tum elicit the expression of acute-phase reactants such as CRP and fibrinogen (29) . Mitigation of the abnormal increase in these inflammatory markers by algal SPS projects their anti-inflammatory role.
Hypercholesterolemia markedly upregulates iNOS expression (30) , and the large quantities of NO generated by iNOS react with superoxide to form peroxynitrate, a powerful oxidizing intermediate (31) . Furthermore, iNOS pathway is found to crosslink with COX-2 pathway (32), and COX activity can produce the superoxide anion (33) thus providing the potential for peroxynitrate formation. The increased NO levels in the present study might be due to increased expression of iNOS. NO is unstable and rapidly oxidizes to nitrite and predominantly nitrate, collectively referred to as NO (34) . Algal SPS were able to mitigate the lipemic-nitrosative-inflammatory stress in atherosclerotic lesion development, probably by the underlying mechanism by which they exerted their hypolipidemic action.
The marked increase in the lysosomal enzymes (Table III) reflects an elevated accumulation of lipids and lipoproteins in the cholesterol-fed rats (Table  II) , in an attempt to facilitate the disposal of excess lipids. The results concur with that of Beratis et al. (35) .
The sum of the present investigation is that algal SPS has been found to exert a positive role in countering the detrimental changes characteristic of hypercholesterolemia and related nitrosativeinflammatory abnormalities. Both SPS from S. wightii and SPS from F. vesiculosus were almost equally effective anti-atherogenic and antiinflammatory candidates.
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